These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27975102)

  • 1. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?
    Santovito D; Weber C
    Thromb Haemost; 2017 Jan; 117(2):231-237. PubMed ID: 27975102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 6. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
    Fredman G; MacNamara KC
    Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.
    Taleb S; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis.
    van Diepen JA; Berbée JF; Havekes LM; Rensen PC
    Atherosclerosis; 2013 Jun; 228(2):306-15. PubMed ID: 23518178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation and atherosclerosis: fulfilling Koch's postulates.
    Jialal I; Vikram NK
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):5-6. PubMed ID: 29187060
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology.
    Tuñón J; Badimón L; Bochaton-Piallat ML; Cariou B; Daemen MJ; Egido J; Evans PC; Hoefer IE; Ketelhuth DFJ; Lutgens E; Matter CM; Monaco C; Steffens S; Stroes E; Vindis C; Weber C; Bäck M
    Cardiovasc Res; 2019 Jan; 115(1):10-19. PubMed ID: 30534957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.
    Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Inflammatory Biomarkers in the Detection and Therapy of Atherosclerotic Disease.
    Poredos P; Jezovnik MK
    Curr Vasc Pharmacol; 2016; 14(6):534-546. PubMed ID: 27357185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.